An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia

1. Martínez, A.
2. San Miguel, J.F.
3. Vidriales, M.-B.
4. Ciudad, J.
5. Caballero, M.D.
6. López-Berges, M.C.
7. Moro, M.J.
8. Calmuntia, M.J.
9. Ortega, F.
10. Orfao, A.